Preprint
Article

This version is not peer-reviewed.

Anti-Inflammatory Effect of Rice Protein in the Disease Initiated by the Spinal Cord Injury in the Rat Model

Submitted:

22 April 2026

Posted:

23 April 2026

You are already at the latest version

Abstract
Background/Objectives: Treatments of inflammatory ailments of the central nervous system including diseases of an aging brain and of mood disorders are not satisfactory or non-existent despite a great and increasing demand. We performed a preclinical study to measure and characterize anti-neuroinflammatory activity unexpectedly associated with rice protein. Methods: Rice protein was administered orally continuously at 12-48 mg, 3 times per day to rats with the spinal cord injury (SCI) and the anti-neuroinflammatory effect measured by the standardized macrophage count in the cavity of injury (COI) test to determine a dose-dependent effect at 7 days post-SCI. The dose of 24 mg was used to characterize the macrophage-lowering effect from 7-56 days postSCI.Results: Rice protein had macrophage-lowering effect which was enhanced with increasing dose. The macrophage-lowering effect of the highest dose tested, 48 mg, was 45.6% vs 100% in untreated rats at 7 days post-SCI. Continuous administration of a dose of 24 mg for 56 days resulted in consistent reduction of macrophage counts.Conclusions: Oral administration of rice protein potently reduced severe, destructive inflammation initiated by SCI. Rice protein, as a GRAS (generally accepted as safe) food supplement may contribute to effective dietary management of ailments of the brain with inflammatory pathogenesis.
Keywords: 
;  ;  ;  ;  ;  ;  ;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated